The unprecedented coronavirus pandemic resulted in another unprecedented event when the sponsors of the first four COVID-19 vaccine candidates to reach Phase III in the US each made public their trial’s clinical protocol document.
The normally confidential clinical protocols were released amidst rising public concern about the COVID-19 vaccine development process. A comparison of...